These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9128268)

  • 1. Telomerase activity in human urothelial tumors.
    Kyo S; Kunimi K; Uchibayashi T; Namiki M; Inoue M
    Am J Clin Pathol; 1997 May; 107(5):555-60. PubMed ID: 9128268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer.
    Kinoshita H; Ogawa O; Kakehi Y; Mishina M; Mitsumori K; Itoh N; Yamada H; Terachi T; Yoshida O
    J Natl Cancer Inst; 1997 May; 89(10):724-30. PubMed ID: 9168188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinosarcoma of urothelial organs: sequential involvement of urinary bladder, ureter, and renal pelvis.
    Orsatti G; Corgan FJ; Goldberg SA
    Urology; 1993 Mar; 41(3):289-91. PubMed ID: 8442318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.
    Lee DH; Yang SC; Hong SJ; Chung BH; Kim IY
    Clin Cancer Res; 1998 Mar; 4(3):535-8. PubMed ID: 9533519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase activity in diagnosis of bladder cancer.
    Erdem E; Dikmen G; Atsü N; Dogan P; Ozen H
    Scand J Urol Nephrol; 2003; 37(3):205-9. PubMed ID: 12775275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semi-quantitative analysis of telomerase activity in exfoliated human urothelial cells and bladder transitional cell carcinoma.
    Yokota K; Kanda K; Inoue Y; Kanayama H; Kagawa S
    Br J Urol; 1998 Nov; 82(5):727-32. PubMed ID: 9839590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of Lymphatic Metastases in Upper Tract Urothelial Carcinoma and Proposed Dissection Templates.
    Matin SF; Sfakianos JP; Espiritu PN; Coleman JA; Spiess PE
    J Urol; 2015 Dec; 194(6):1567-74. PubMed ID: 26094807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology and staging of urothelial tumors of the kidney and ureter.
    Melamed MR; Reuter VE
    Urol Clin North Am; 1993 May; 20(2):333-47. PubMed ID: 8388136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase activity in human bladder cancer.
    Lin Y; Miyamoto H; Fujinami K; Uemura H; Hosaka M; Iwasaki Y; Kubota Y
    Clin Cancer Res; 1996 Jun; 2(6):929-32. PubMed ID: 9816252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase activity in gynecological tumors.
    Kyo S; Kanaya T; Ishikawa H; Ueno H; Inoue M
    Clin Cancer Res; 1996 Dec; 2(12):2023-8. PubMed ID: 9816162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathway.
    Liu JY; Qian D; He LR; Li YH; Liao YJ; Mai SJ; Tian XP; Liu YH; Zhang JX; Kung HF; Zeng YX; Zhou FJ; Xie D
    Mol Cancer; 2013 Nov; 12(1):148. PubMed ID: 24268029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative measurement of telomerase reverse transcriptase (hTERT) mRNA in urothelial cell carcinomas.
    De Kok JB; Schalken JA; Aalders TW; Ruers TJ; Willems HL; Swinkels DW
    Int J Cancer; 2000 Jul; 87(2):217-20. PubMed ID: 10861477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low frequency of positive telomerase activity in a chromophobe subtype of renal cell carcinoma.
    Kinoshita H; Ogawa O; Mitsumori K; Kakehi Y; Terachi T; Yoshida O
    J Urol; 1998 Jan; 159(1):245-51. PubMed ID: 9400489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR.
    Wang K; Liu T; Ge N; Liu L; Yuan X; Liu J; Kong F; Wang C; Ren H; Yan K; Hu S; Xu Z; Björkholm M; Fan Y; Zhao S; Liu C; Xu D
    Oncotarget; 2014 Dec; 5(23):12428-39. PubMed ID: 25474136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination of semiquantitative telomerase assay and in-cell telomerase activity measurement using exfoliated urothelial cells for the detection of urothelial neoplasia.
    Ohyashiki K; Yahata N; Ohyashiki JH; Iwama H; Hayashi S; Ando K; Aizawa T; Ito T; Miki M; Ebihara Y
    Cancer; 1998 Dec; 83(12):2554-60. PubMed ID: 9874463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypoid urothelial tumor with inverted growth pattern in the renal pelvis: morphologic and molecular characteristics of a unique diagnostic entity.
    Wobker SE; Zhong M; Epstein JI
    Hum Pathol; 2017 Jan; 59():26-33. PubMed ID: 27574810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
    Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA
    Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of urinary telomerase activity measurement in urothelial cancer.
    Arai Y; Yajima T; Yagihashi A; Kobayashi D; Kameshima H; Sasaki M; Tanaka K; Kuwajima K; Miyao N; Tsukamoto T; Watanabe N
    Clin Chim Acta; 2000 Jun; 296(1-2):35-44. PubMed ID: 10807969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Simultaneous bilateral renal pelvic tumors: a case report].
    Kanai S; Takagi Y; Tanaka J; Miyake K
    Hinyokika Kiyo; 1991 Dec; 37(12):1703-5. PubMed ID: 1785396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase activity: a potential marker of bladder transitional cell carcinoma in bladder washes.
    Yang SC; Lee DH; Hong SJ; Chung BH; Kim IY
    Yonsei Med J; 1997 Jun; 38(3):155-9. PubMed ID: 9259615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.